Merck Price Target Raised by Scotiabank Analysts

Scotiabank analysts raised their price target for Merck & Co., Inc. (NYSE:MRK) to $180.00 from $155.00, indicating a potential upside of 22.81%.

This is the latest in a series of revisions, with Wells Fargo & Company raising its target price to $170.00 and Cantor Fitzgerald maintaining a 'neutral' rating with a $120.00 price objective.

The company's stock has been traded down 1.4% to $146.57, with 1,375,664 shares exchanged compared to its average volume of 10,703,549.